NRX Pharmaceuticals Inc (NRXPW)
NASDAQ
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -0.302 | 0.094 | 0.793 | -291.278 | -1956.182 | -135.807 | -182.059 |
Return on Equity (%) | -4.2 | 1.32 | 8.16 | 263.013 | 3037.348 | -281.793 | 1394.958 |
Return on Invested Capital (%) | 0.419 | 3.169 | 146.239 | 234.671 | 1031.544 | -286.023 | 2849.232 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 1.93 | 25.519 | 10.373 | -16.288 | 0.338 | 0.107 | -0.136 |
Earnings Per Share | -0.041 | 0.024 | 0.143 | -18.972 | -5.673 | -0.575 | -0.348 |
Cash Per Share | 0.173 | 0.004 | N/A | 0.692 | 0.449 | 0.29 | 0.053 |
Working Capital Per Share | 0.171 | -0.197 | -0.194 | -16.087 | 0.338 | 0.148 | -0.14 |
Operating Profit Per Share | -0.052 | N/A | N/A | 3.78 | 0.013 | N/A | N/A |
EBIT Per Share | -0.041 | 0.03 | 0.173 | -18.972 | -1.513 | -0.575 | -0.348 |
EBITDA Per Share | -0.041 | 0.03 | 0.173 | -18.972 | -1.513 | -0.575 | -0.348 |
Free Cash Flow Per Share | -0.041 | 0.024 | 0.143 | -18.972 | -5.673 | -0.575 | -0.348 |
Fin d'année 31 Décembre 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 2,59M | 2,73M | 2,84M | 2,69M | 58,81M | 66,44M | N/A |
Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Actions en circulation | 66,44M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 17,54M |
Ratio cours/bénéfice | -9,36 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 61,39 |
Ratio prix/valeur comptable | -24,06 |
Rendement de dividende | - |
Actions en circulation | 86,61M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | - |
Plus haut sur 52 semaines | - |
Plus bas sur 52 semaines | - |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales